Skip navigation
BelSU DSpace logo

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 14 (Search time: 0.01 seconds).
Item hits:
Issue DateTitleAuthor(s)
2015Simulation of total brain ischemia in ratsMartynova, O. V.; Gureev, V. V.; Pokrovskiy, M. V.; Martynov, M. A.; Solgalova, A. S.
2015Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010Gureev, V. V.; Martynova, O. V.; Anciferova, O. E.; Martynov, M. A.; Pokrovskaia, T. G.
2019L-NAME-induced preeclampsia: correction of functional disorders of the hemostasis system with resveratrol and nicorandilStupakova, E. G.; Lazareva, G. A.; Gureev, V. V.; Dolzhikova, I. N.; Zhilinkova, L. A.
2019Influence of silver-ion-containing pharmacotherapeutic system for repair of anterior abdominal wall on connective tissue formation in experimentMishina, E. S.; Zatolokina, M. A.; Gureeva, A. V.; Gureev, V. V.; Elagina, K. A.
2019Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsiaSeverinova, O. V.; Gureev, V. V.; Zhilinkova, L. A.; Lazareva, G. A.; Gureeva, A. V.
2018Evaluation of pharmacological correction of L-NAME-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin detralex 1000 mgLukyanova, Y. S.; Kolesnichenko, P. D.; Gureev, V. V.; Zhilinkova, L. A.
2018Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandilStupakova, E. G.; Lazareva, G. A.; Gureev, V. V.
2016New approaches of morfofunktional pharmacological correction of violations of cardiovascular system in experimental preeclampsiaGureev, V. V.
2015The effect of humoral factors released by hypoperfused placenta on fetal developmentGureev, V. V.; Antseferova, O. Y.; Lokteva, T. I.; Dolzhikov, A. A.
2020Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsiaLokteva, T. I.; Rozhkov, I. S.; Gureev, V. V.; Gureeva, A. V.; Zatolokina, M. A.